Pipeline· May 27, 2026 · 7 min read
Antibody-drug conjugate access landscape: 14 FDA-approved ADCs, payer coverage, and the pipeline watch
By Ran Chen#ADC#HER2#Prior Authorization
Antibody-drug conjugates, oncology evidence, label expansion, payer access, coding, and commercialization.